Status:
UNKNOWN
Metformin Treatment in Polycystic Ovary Syndrome (PCOS)
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
University of Utah
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
PCOS occurs when a woman does not release an egg regularly each month, causing her periods to be irregular. Women with PCOS can also have increased hair growth on the face and body, acne, head balding...
Detailed Description
Women who are eligible to enroll in this study will be treated with the medication metformin for 12 weeks. Before and after treatment with metformin, the following will be assessed: * Weight, blood p...
Eligibility Criteria
Inclusion
- Polycystic ovary syndrome
- No hormonal or antidiabetic medications for 1 month
- Good general health
Exclusion
- Smoker
- Acute infection or chronic disease
- Diabetes
- Pregnant or trying to get pregnant over next half year
- Bleeding disorders
- Any metal or foreign implants (e.g., aneurysm clips, ear implants, heart pacemakers or defibrillators)
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02198417
Start Date
July 1 2014
End Date
December 1 2020
Last Update
August 16 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.